t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism

Cancer Research
Abbes BelkhiriWael El-Rifai

Abstract

t-Darpp is a cancer-related truncated isoform of Darpp-32 (dopamine and cyclic-AMP-regulated phosphoprotein of M(r) 32,000). We detected overexpression of t-Darpp mRNA in two thirds of gastric cancers compared with normal samples (P = 0.004). Using 20 micromol/L ceramide treatment as a model for induction of apoptosis in AGS cancer cells, we found that expression of t-Darpp led to an increase in Bcl2 protein levels and blocked the activation of caspase-3 and caspase-9. The MitoCapture mitochondrial apoptosis and cytochrome c release assays indicated that t-Darpp expression enforces the mitochondrial transmembrane potential and protects against ceramide-induced apoptosis. Interestingly, the expression of t-Darpp in AGS cells led to >or=2-fold increase in Akt kinase activity with an increase in protein levels of p-Ser(473) Akt and p-Ser(9) GSK3 beta. These findings were further confirmed using tetracycline-inducible AGS cells stably expressing t-Darpp. We also showed transcriptional up-regulation of Bcl2 using the luciferase assay with Bcl2 reporter containing P1 full promoter, quantitative reverse transcription-PCR, and t-Darpp small interfering RNA. The Bcl2 promoter contains binding sites for cyclic AMP-responsive element bind...Continue Reading

References

Mar 1, 1989·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·H C HemmingsP Greengard
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·K L WidnellE J Nestler
Mar 15, 1997·Genes & Development·S G KennedyN Hay
Aug 1, 1997·Nature Genetics·D J MarshC Eng
Oct 31, 1998·The Biochemical Journal·S MathiasR N Kolesnick
Nov 26, 1998·The Journal of Biological Chemistry·K Du, M Montminy
Apr 14, 1999·CA: a Cancer Journal for Clinicians·D M ParkinJ Ferlay
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·D M ParkinP Pisani
May 29, 2002·Oncogene·Caroline A HeckmanLinda M Boxer
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
Jan 4, 2003·The Medical Clinics of North America·Stuart Jon Spechler
Feb 6, 2003·International Journal of Cancer. Journal International Du Cancer·Wei ShiFei-Fei Liu
Aug 26, 2003·Human Mutation·Charis Eng
Sep 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hongbo R LuoSolomon H Snyder
Mar 5, 2004·Biochimica Et Biophysica Acta·Vladimir KirkinMartin Zörnig
Mar 16, 2004·Science·Yardena SamuelsVictor E Velculescu
Sep 17, 2004·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·A MayerhoferP Greengard
Sep 24, 2004·Cancer Cell·Anthony LetaiStanley J Korsmeyer
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Mar 24, 2005·BMC Cancer·Vivian Sze Wing LiSuet Yi Leung
May 19, 2005·International Journal of Cancer. Journal International Du Cancer·Eiji OkiYoshihiko Maehara
May 20, 2005·Nature·Tilman OltersdorfSaul H Rosenberg
Jul 5, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sérgia VelhoRaquel Seruca
Aug 3, 2005·Cancer Research·Abbes BelkhiriWa'el El-Rifai
Nov 22, 2005·Journal of Surgical Oncology·Manuel PeraLuis Grande
Dec 13, 2005·Nature Reviews. Drug Discovery·Bryan T HennessyGordon B Mills
Apr 8, 2006·Endocrine-related Cancer·P Kauraniemi, A Kallioniemi
Oct 19, 2006·Cancer Cell·Neal Rosen, Qing-Bai She

❮ Previous
Next ❯

Citations

Dec 20, 2012·Pathology Oncology Research : POR·Despina TelevantouVassiliki Kotoula
May 5, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hee-Seong JangKwon Moo Park
Jun 27, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Abbes BelkhiriWael El-Rifai
May 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Abbes BelkhiriWael El-Rifai
Sep 16, 2008·Molecular Cancer Therapeutics·Xuening WangGeorge P Studzinski
Mar 31, 2011·Molecular Cancer·Bhavatarini VangamudiWael El-Rifai
Jun 12, 2010·Molecular Cancer·Rajakishore Mishra
Nov 28, 2013·Archivum Immunologiae Et Therapiae Experimentalis·Shegan GaoXiaoshan Feng
Feb 9, 2011·Journal of Cellular Physiology·James A McCubreyAlberto M Martelli
Mar 17, 2010·International Journal of Cancer. Journal International Du Cancer·Harmony F TurkRobert S Chapkin
Aug 17, 2014·Molecular Cancer·Jessica L Christenson, Susan E Kane
May 29, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Guo-Liang HuangZhi-Wei He
Oct 31, 2013·Advances in Biological Regulation·James A McCubreyLinda S Steelman
Apr 8, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yasuto KuniiHirooki Yabe
Jul 20, 2016·Pharmacology Research & Perspectives·Vitor CaiaffoJoaquim Evêncio Neto
Aug 1, 2016·Neuroscience·Marco StracciaJosep M Canals
Mar 2, 2019·Stress : the International Journal on the Biology of Stress·Hongzhao ShiShize Li
Feb 13, 2016·Oncotarget·Abbes BelkhiriWael El-Rifai
Jun 17, 2014·Oncotarget·James A McCubreyMelchiorre Cervello

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis